DeepMed Research

National Eye Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1968-01-01

Employees: 101

Market Cap: -

Website: http://www.nei.nih.gov

Clinical Trials

Efalizumab to Treat Uveitis

Phase 1

Completed

Conditions: Uveitis
Macular Edema

Interventions: Drug: Efalizumab

First Posted Date: 2006-01-23

Last Posted Date: 2011-02-02

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 6

Registration Number: NCT00280826

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Clinical and Genetic Studies in Families With Myopia and Related Diseases

Completed

Conditions: Myopia

First Posted Date: 2006-01-05

Last Posted Date: 2019-12-12

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 851

Registration Number: NCT00272376

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
🇨🇳
Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzho, China

Clinical and Molecular Studies in Families With Glaucoma and Related Diseases

Completed

Conditions: Glaucoma

First Posted Date: 2006-01-05

Last Posted Date: 2019-12-05

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 484

Registration Number: NCT00272363

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States
🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
🇺🇸
Duke University, Durham, North Carolina, United States

and more 1 locations

Correlation of Gene Abnormalities and Clinical Manifestations of Aniridia

Completed

Conditions: Aniridia

First Posted Date: 2005-12-14

Last Posted Date: 2017-07-02

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 100

Registration Number: NCT00265590

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States

Molecular Genetics of Retinal Degenerations

Completed

Conditions: Retinal Degeneration
Retinitis Pigmentosa

First Posted Date: 2005-10-03

Last Posted Date: 2018-04-05

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 3549

Registration Number: NCT00231010

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
🇺🇸
Harvard Medical School, Boston, Massachusetts, United States
🇺🇸
Cleveland Clinic Foundation Childrens Hospital, Cleveland, Ohio, United States

and more 3 locations

Triamcinolone Acetonide Injections to Treat Diabetic Macular Edema

Phase 2

Completed

Conditions: Diabetic Retinopathy

First Posted Date: 2005-10-03

Last Posted Date: 2008-03-04

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 10

Registration Number: NCT00231023

Locations: 🇺🇸
National Eye Institute (NEI), Bethesda, Maryland, United States

Human Anti-Tac (Daclizumab) to Treat Juvenile Idiopathic Arthritis (JIA)-Associated Uveitis

Phase 2

Completed

Conditions: Anterior Uveitis
Arthritis, Juvenile Idiopathic
Iritis
Immunosuppression

Interventions: Drug: Daclizumab

First Posted Date: 2005-08-15

Last Posted Date: 2017-01-30

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 6

Registration Number: NCT00130637

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Lutein/Zeaxanthin and Omega-3 Supplementation in Persons Over Age 60

Phase 1

Completed

Conditions: Macular Degeneration

First Posted Date: 2005-07-21

Last Posted Date: 2017-07-02

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 40

Registration Number: NCT00121589

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study

Completed

Conditions: Cancer
Infection
Mortality
Immunosuppression
Uveitis

First Posted Date: 2005-06-27

Last Posted Date: 2017-07-02

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 6300

Registration Number: NCT00116090

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸
Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States

and more 1 locations

Clinical and Genetic Studies of Familial Exudative Vitreoretinopathy

Completed

Conditions: FEVR
Avascular Retina
Familial Exudative Vitreoretinopathy
Retina Fold
Eye Diseases
Exudatiaon

First Posted Date: 2005-03-30

Last Posted Date: 2017-07-02

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 105

Registration Number: NCT00106756

Locations: 🇨🇦
Izaak Walton Killam Grace Health Centre, Halifax, Canada
🇬🇧
St. James University, Leeds, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy